Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
White House announces COVID-19 vaccine plan for children aged 5 to 11 years
The White House announced a rollout plan to vaccinate children aged 5 to 11 years against COVID-19 should the FDA authorize the use of the Pfizer-BioNTech vaccine in this age group.
Interferon adds no clinical benefit for hospitalized patients with COVID-19
Combining the immunomodulator interferon beta-1a with remdesivir did not improve treatment among hospitalized adults with COVID-19 compared with remdesivir alone, data from a clinical trial showed.
Log in or Sign up for Free to view tailored content for your specialty!
ACP partners with YouTube to combat COVID-19 misinformation
The ACP announced that it is working with YouTube to develop messages to counteract misinformation about COVID-19, its treatment and vaccines.
Physicians 'practicing medicine blind' in areas without adequate access to diagnostics
Nearly half of the world’s population, primarily in low- and middle-income countries, has little to no access to essential diagnostic tools for common diseases, according to findings published by The Lancet Commission on Diagnostics.
Lefamulin a safe, effective alternative to moxifloxacin for unilobar, multilobar pneumonia
In a pooled analysis of the LEAP 1 and LEAP 2 trials, lefamulin was safe and its efficacy was comparable to that of moxifloxacin in patients with unilobar and multilobar community-acquired bacterial pneumonia.
Rapid assay accurately detects drug-resistant TB
A rapid sputum-based assay accurately detected resistance to isoniazid, fluoroquinolones, ethionamide, amikacin, kanamycin and capreomycin in people with tuberculosis symptoms, showing its potential to diagnose drug-resistant TB.
FDA committee recommends second J&J shot at 2 months
An FDA advisory committee on Friday unanimously recommended that anyone who received the Johnson & Johnson COVID-19 vaccine should be able to receive a second dose at least 2 months after receiving their initial shot.
FDA advisory committee unanimously recommends Moderna booster shot
An FDA advisory committee on Thursday unanimously recommended the authorization of a booster dose of Moderna’s COVID-19 messenger RNA vaccine for certain people, to be given at half the regular dose.
‘A global wake-up call’: In shadow of COVID-19, TB deaths rise for first time in 15 years
Disruptions caused by the COVID-19 pandemic have reversed years of global progress in the fight against tuberculosis, leading to an increase in deaths from TB for the first time in over a decade, according to WHO’s 2021 Global TB report.
More than half of COVID-19 survivors experience symptoms 6 months after recovery
More than half of COVID-19 survivors experience symptoms consistent with long COVID up to 6 months after recovery, data from a systematic review published in JAMA Network Open showed.
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read
-
Headline News
Q&A: What is driving ‘disturbing’ rise in metastatic stomach cancer in young adults?
September 27, 20245 min read -
Headline News
Prenatal cannabis use in California nearly doubled amid legalization from 2012 to 2022
September 26, 20242 min read -
Headline News
'Encouraging': Antiviral ziresovir shows promise against RSV in infants
September 26, 20242 min read